Athira’s Alzheimer’s Therapy Climbs Ranks in a Competitive Space

Athira Pharma’s experimental Alzheimer's therapy, fosgonimeton, continues to show reductions in known biomarkers associated with the disease and signs of cognitive and functional improvement in patients with mild-to-moderate Alzheimer's.